About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Frontal Giant Cell Reparative Granuloma Invading Orbit Mimicking Meningioma Radiologically

internet drug coupons

cialis coupon
ARDIC YUKRUK Fisun¹, AYATA KEBAT Tulu¹, SIMSEK Zekiye², BASMACI Mehmet3
Departments of 1Pathology, 2Radiology, 3Neurosurgery; Government of Health, Ankara Oncology Training and Research Hospital, Ankara/Turkey.
Corresponding Author:
Dr. Fisun Ardic Yukruk
Email: fisun01@gmail.com
Received: 19-APR-2015 Accepted: 5-AUG-2015 Published Online: 25-AUG-2015
DOI: http://dx.doi.org/10.17659/01.2015.0093
Abstract
We report a case of giant cell reparative granuloma (GCRG) arising in the left frontal and superior orbital region of a 20 year old woman. On magnetic resonance images this lesion had a dural tail which is a typical finding of meningioma.
Keywords : Giant Cells, Giant Cell Granuloma, Magnetic Resonance Imaging, Meningeal Neoplasms, Meningioma.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 19, 2025